MedTrace Logo

Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients

NCT02604472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12206

Last updated 2015-11-13

No results posted yet for this study

Summary

To investigate whether the additional induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) was able to improve overall survival (OS) and disease-free survival (DFS), and to clarify if stage-specified chemoradiotherapy regimens benefit the most for locoregionally advanced NPC.

Conditions

  • Malignant Neoplasm of Other Specified Site of Nasopharynx

Interventions

OTHER

CCRT

Locoregionally advanced nasopharyngeal carcinoma patients received platinum-based/non-platinum based concurrent chemoradiotherapy.

OTHER

IC+CCRT

Locoregionally advanced nasopharyngeal carcinoma patients received induction chemotherapy and platinum-based/non-platinum based concurrent chemoradiotherapy.

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Xiang Guo, MD, PhD · Sun Yat-sen University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-01-31
Primary Completion
2013-06-30
Completion
2015-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02604472 on ClinicalTrials.gov